NBSE
NeuBase Therapeutics, Inc. Common Stock
NBSE
NBSE
Delisted
NBSE was delisted on the 10th of May, 2024.
57 hedge funds and large institutions have $55.8M invested in NeuBase Therapeutics, Inc. Common Stock in 2014 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 16 increasing their positions, 4 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
37% less call options, than puts
Call options by funds: $4.99M | Put options by funds: $7.9M
Holders
57
Holding in Top 10
–
Calls
$4.99M
Puts
$7.9M
Top Buyers
| 1 | +$10.5M | |
| 2 | +$4.92M | |
| 3 | +$4.54M | |
| 4 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
+$2.85M |
| 5 |
State Street
Boston,
Massachusetts
|
+$1.77M |
Top Sellers
| 1 | -$2.23M | |
| 2 | -$880K | |
| 3 | -$785K | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$663K |
| 5 |
GC
Gratia Capital
Los Angeles,
California
|
-$658K |